Concepedia

Publication | Open Access

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer

22

Citations

36

References

2021

Year

Abstract

The combination of cabozantinib and panitumumab has activity. Dose reductions of cabozantinib improve tolerability.

References

YearCitations

Page 1